Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
0.4278
-0.0291 (-6.37%)
At close: Mar 28, 2025, 4:00 PM
0.4301
+0.0023 (0.54%)
Pre-market: Mar 31, 2025, 8:22 AM EDT
Generation Bio Co. Employees
Generation Bio Co. had 115 employees as of December 31, 2024. The number of employees decreased by 59 or -33.91% compared to the previous year.
Employees
115
Change (1Y)
-59
Growth (1Y)
-33.91%
Revenue / Employee
$172,974
Profits / Employee
-$1,144,939
Market Cap
28.67M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 115 | -59 | -33.91% |
Dec 31, 2023 | 174 | 24 | 16.00% |
Dec 31, 2022 | 150 | 0 | - |
Dec 31, 2021 | 150 | 50 | 50.00% |
Dec 31, 2020 | 100 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GBIO News
- 17 days ago - Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 7 weeks ago - Tubulis Strengthens Executive Leadership with Appointment of Matthew Norkunas as Chief Financial Officer and President of Tubulis Inc. - Business Wire
- 2 months ago - Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases - GlobeNewsWire
- 5 months ago - Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress - GlobeNewsWire
- 7 months ago - Generation Bio to Present at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 8 months ago - Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference - GlobeNewsWire
- 10 months ago - Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit - GlobeNewsWire